thyroid and glp 1 Glucagon-like peptide receptor agonist use risk of cancer: Scandinavian cohort study GLP-1 medications and thyroid cancer
Description
They're not leaving alcohol
Clinical evidence remains limited
Learn what happens and how to restart therapy safely.
This review addresses the role of semaglutide (SMG), a GLP-1 receptor agonist, in the treatment of obesity and its related comorbidities
